Examples of PACT Collaborator in a sentence
In all oral presentations or written publications arising from the use of the Human Material from PACT-Funded Trials, PACT-Funded CIMAC Data, or PACT Results, the PACT team (including NCI and industry sponsors), CIMAC-CIDC, PACT Collaborator, and Provider will be acknowledged unless requested otherwise.Acknowledgement language for the PACT team will be provided to each Supplemental Biomarker Analysis Team.
However, information proprietary to the PACT Collaborator may be redacted at the PACT Collaborator’s request.
All manuscripts, abstracts, presentations, or posters using data and/or materials from clinical trials using Agent(s) provided by PACT Collaborator(s), will be sent to FNIH, c/o Stacey Adam at sadam@fnih.org and Jenny Peterson-Klaus at jpeterson- klaus@fnih.org for advisory review and comment by the PACT JSC and the PACT Collaborator no later than thirty (30) days before submission for proposed manuscripts and seven (7) days before disclosure for proposed abstracts or presentations.
The PACT Collaborator shall have the right to request that publication be delayed for up to an additional thirty (30) days in order to ensure that the PACT Collaborator’s confidential and proprietary data, in addition to the PACT Collaborator(s)’s intellectual property rights, are protected.
Prior to the end of the Embargo Period, FNIH will contact the PACT Collaborator to see if an extension of the Embargo Period for regulatory filing is required.
Note: While PACT Collaborator comments are not binding, authors must address all comments made by PACT Collaborator.
Since most PACT-Funded Trials will use Human Material from existing approved clinical trials from other Clinical Trial Networks/Clinical Research Sites, the CIMAC-CIDC data sharing plans must also comply with the existing data release timelines within these existing Protocol agreements between the Clinical Trial Team and the PACT Collaborator.
Following publication of the supplementary biomarker data in a manuscript, the PACT Collaborator may perform additional analyses for internal use or that are planned for publication, including via manuscripts, abstracts, or corporate publications, of their PACT-Funded CIMAC Data in coordination with and approval from the Supplementary Biomarker Analysis Team, and notification to the PACT JSC.
The Embargo Period may be extended on PACT Collaborator request to PACT JSC.
As appropriate, Provider will share Clinical Data, PACT-Funded CIMAC Data, and PACT Results with PACT Collaborator with notification to PACT JSC/FNIH.